Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course

Schizophrenia Research

Volumn 166, Issue 1-3, 2015, Pages 238-247

  Hadar, Ravit ^a   Soto Montenegro, M Luisa ^b,c   Götz, Thomas ^a   Wieske, Franziska ^a   Sohr, Reinhard ^a   Desco, Manuel ^b,c   Hamani, Clement ^f   Weiner, Ina ^e   Pascau, Javier ^b,d   Winter, Christine ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

FDG PET; Neurobiological trajectories; Neurotransmission; Poly I:C; Schizophrenia; Sensorimotor deficits

Indexed keywords

DOPAMINE; FLUORODEOXYGLUCOSE F 18; SEROTONIN; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CAUDATE NUCLEUS; CONTROLLED STUDY; GLOBUS PALLIDUS; GLUCOSE TRANSPORT; HIPPOCAMPUS; IMMUNOSTIMULATION; MALE; MATERNAL IMMUNE STIMULATION; MEDIAL PREFRONTAL CORTEX; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORY GATING; ANIMAL; BRAIN; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; FEMALE; GROWTH, DEVELOPMENT AND AGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RADIOGRAPHY; SCINTISCANNING; STARTLE REFLEX; WISTAR RAT;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RADIOPHARMACEUTICALS; RATS, WISTAR; REFLEX, STARTLE; SCHIZOPHRENIA; SENSORY GATING; SEROTONIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84955410773     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.05.010     Document Type: Article

References (30)

1. Abi-Dargham A., Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 2003, 9(5):404-416.
2. Alam M., Angelov S., Stemmler M., von Wrangel C., Krauss J.K., Schwabe K. Neuronal activity of the prefrontal cortex is reduced in rats selectively bred for deficient sensorimotor gating. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2015, 56:174-184.
3. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156(2-3):234-258.
4. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156(2-3):117-154.
5. Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., Winter C., Riva M.A., Mortensen P.B., Feldon J., Schedlowski M., Meyer U. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (New York, N.Y.) 2013, 339(6123):1095-1099.
6. Giulivi C., Napoli E., Schwartzer J., Careaga M., Ashwood P. Gestational exposure to a viral mimetic poly(i:C) results in long-lasting changes in mitochondrial function by leucocytes in the adult offspring. Mediat. Inflamm. 2013, 2013:609602.
7. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1998, 1(4):318-323.
8. Klein J., Hadar R., Gotz T., Manner A., Eberhardt C., Baldassarri J., Schmidt T.T., Kupsch A., Heinz A., Morgenstern R., Schneider M., Weiner I., Winter C. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimul. 2013, 6(4):490-499.
9. Mattei D., Djodari-Irani A., Hadar R., Pelz A., de Cossio L.F., Goetz T., Matyash M., Kettenmann H., Winter C., Wolf S.A. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav. Immun. 2014, 38:175-184.
10. McGlashan T.H., Zipursky R.B., Perkins D., Addington J., Miller T., Woods S.W., Hawkins K.A., Hoffman R.E., Preda A., Epstein I., Addington D., Lindborg S., Trzaskoma Q., Tohen M., Breier A. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am. J. Psychiatry 2006, 163(5):790-799.
11. Medoff D.R., Holcomb H.H., Lahti A.C., Tamminga C.A. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 2001, 11(5):543-550.
12. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90(3):285-326.
13. Meyer U., Feldon J. To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 2012, 62(3):1308-1321.
14. Meyer U., Knuesel I., Nyffeler M., Feldon J. Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology 2010, 208(4):531-543.
15. Ming G.L., Song H. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 2005, 28:223-250.
16. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 2006, 59(6):546-554.
17. Pascau J., Gispert J.D., Michaelides M., Thanos P.K., Volkow N.D., Vaquero J.J., Soto-Montenegro M.L., Desco M. Automated method for small-animal PET image registration with intrinsic validation. Mol. Imaging Biol. 2009, 11(2):107-113.
18. Piontkewitz Y., Assaf Y., Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol. Psychiatry 2009, 66(11):1038-1046.
19. Piontkewitz Y., Arad M., Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol. Psychiatry 2011, 70(9):842-851.
20. Piontkewitz Y., Arad M., Weiner I. Tracing the development of psychosis and its prevention: what can be learned from animal models. Neuropharmacology 2012, 62(3):1273-1289.
21. Romero E., Guaza C., Castellano B., Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol. Psychiatry 2010, 15(4):372-383.
22. Schobel S.A., Lewandowski N.M., Corcoran C.M., Moore H., Brown T., Malaspina D., Small S.A. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch. Gen. Psychiatry 2009, 66(9):938-946.
23. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 2008, 199(3):331-388.
24. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167(10):1178-1193.
25. Volk D.W., Lewis D.A. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia. Schizophr. Bull. 2014, 40(5):952-957.
26. Weiss A.P., Schacter D.L., Goff D.C., Rauch S.L., Alpert N.M., Fischman A.J., Heckers S. Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia. Biol. Psychiatry 2003, 53(1):48-55.
27. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., Meyer U. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int. J. Neuropsychopharmacol. 2009, 12(4):513-524.
28. Winterer G., Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 2004, 27(11):683-690.
29. Wolf S.A., Melnik A., Kempermann G. Physical exercise increases adult neurogenesis and telomerase activity, and improves behavioral deficits in a mouse model of schizophrenia. Brain Behav. Immun. 2011, 25(5):971-980.
30. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. sychopharmacology 2003, 28(10):1778-1789.